<unk> s are quite rare. The risk of a previously healthy person receiving a new diagnosis of bone cancer is less than 0.001%, while the risk of receiving a new diagnosis of soft tissue<unk>  is between 0.0014-0.005%. The American Cancer Society estimates that in the United States there will be 3,500 new cases of bone<unk>  in 2019, and 12,750 new cases of soft tissue<unk> . Considering that the total estimated number of new cancer diagnoses (all types of cancer) is 1,762,450, this means bone<unk> s represent only 0.2% of all new cancer diagnoses (making them the 30th most common type of cancer) and soft tissue<unk> s represent only 0.7% (making them the 22nd most common type of cancer) of all new cancer diagnoses in the US in 2019. These estimates are similar to previously reported data.<unk> s affect people of all ages. Around 50% of bone<unk> s and 20% of soft-tissue<unk> s are diagnosed in people under the age of 35. Some<unk> s, such as leiomyosarcoma, chondrosarcoma, and gastrointestinal stromal tumor (GIST), are more common in adults than in children. Most high-grade bone<unk> s, including Ewing's<unk>  and osteosarcoma, are much more common in children and young adults.
Sarcoma
Angiosarcoma
Soft-tissue sarcoma
Hemangiosarcoma
Xanthoma
Myosarcoma
Epithelioma
Liposarcoma